Cintas Total Cost of Revenue increased by 0.4% to $1.39B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 8.0%, from $1.29B to $1.39B. Over 2 years (FY 2023 to FY 2025), Total Cost of Revenue shows an upward trend with a 5.5% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.16B | $1.16B | $1.16B | $1.16B | $1.23B | $1.23B | $1.23B | $1.23B | $1.25B | $1.29B | $1.29B | $1.34B | $1.35B | $1.39B | $1.39B |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +5.8% | +0.0% | +0.0% | +0.0% | +1.8% | +2.9% | +0.4% | +4.0% | +0.7% | +2.7% | +0.4% |
| YoY Change | — | — | — | — | +5.8% | +5.8% | +5.8% | +5.8% | +1.8% | +4.7% | +5.1% | +9.3% | +8.2% | +8.0% | +8.0% |
| Segment | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 |
|---|---|---|---|---|---|---|---|---|
| Uniform Rental and Facility Services | $983.05M | $981.16M | $1.01B | $1.01B | $1.04B | $1.05B | $1.08B | $1.08B |
| Other | $272.44M | $268.29M | $271.03M | $280.16M | $305.65M | $299.01M | $306.29M | $309.97M |
| Total | $1.23B | $1.25B | $1.29B | $1.29B | $1.34B | $1.35B | $1.39B | $1.39B |